Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 2/20 | 0.45 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.45 |
| ▸ | F11 | P03951 | 15/20 | 0.36 |
| ▸ | UCHL1 | P09936 | 1/20 | 0.33 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.31 |
| ▸ | TPSD1 | Q9BZJ3 | 1/20 | 0.31 |
| ▸ | TPSG1 | Q9NRR2 | 1/20 | 0.31 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8621118 | 0.80 | ITGB3 (0.49) | ITGB3ITGA2BF11TPSAB1TPSD1 | |
| SCHEMBL7365778 | 0.76 | ITGB3 (0.45) | ITGB3ITGA2BF11TPSAB1TPSD1 | |
| SCHEMBL8621921 | 0.74 | ITGB3 (0.58) | ITGB3ITGA2BF11UCHL1TPSAB1 | |
| SCHEMBL29202141 | 0.71 | GABRP (0.49) | TPSAB1TPSD1TPSG1 | |
| SCHEMBL7340771 | 0.70 | ITGB3 (0.70) | ITGB3ITGA2BF11 | |
| SCHEMBL7340777 | 0.70 | ITGB3 (0.70) | ITGB3ITGA2BF11 | |
| Hydrochloric Acid SCHEMBL8622674 | 0.69 | ITGB3 (0.69) | ITGB3ITGA2BF11 | |
| Hydrochloric Acid SCHEMBL8622679 | 0.69 | ITGB3 (0.69) | ITGB3ITGA2BF11 | |
| SCHEMBL8103481 | 0.66 | ITGB3 (0.35) | ITGB3ITGA2BHRH3 | |
| SCHEMBL8622174 | 0.66 | ENO1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0866705-A4 | FIBRINOGEN RECEPTOR ANTAGONISTS | MERCK & CO INC (US) | 1999-03-03 | — | — | EP | claimed |
| EP-0866705-A1 | FIBRINOGEN RECEPTOR ANTAGONISTS | Merck & Co., Inc. (US) | 1998-09-30 | — | — | EP | claimed |
| WO-1997014417-A1 | FIBRINOGEN RECEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 1997-04-24 | — | — | WO | claimed |
| EP-0866705-A4 | FIBRINOGEN RECEPTOR ANTAGONISTS | MERCK & CO INC (US) | 1999-03-03 | — | — | EP | disclosed |
| US-5852045-A | Fibrinogen receptor antagonists | MERCK & CO., INC. (US) | 1998-12-22 | — | — | US | disclosed |
| EP-0866705-A1 | FIBRINOGEN RECEPTOR ANTAGONISTS | Merck & Co., Inc. (US) | 1998-09-30 | — | — | EP | disclosed |
| WO-1997014417-A1 | FIBRINOGEN RECEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 1997-04-24 | — | — | WO | disclosed |